MLYS
$20.30-6.19%
Mineralys Therapeutics Inc.Stock · HealthcareRussell 2000 0.05%Nasdaq Composite 0.006%US Stock Market 0.002%Russell 3000 0.002%
Mineralys Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Mineralys Therapeutics Inc. total returns by year (2024–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $36.29 | $20.30 | 0.0% | -44.1% | |
| 2025 | $12.31 | $36.29 | 0.0% | +194.8% | |
| 2024 | $8.60 | $12.31 | 0.0% | +43.1% |
- Annualized
- +3.7%
- 2024–2026
- Average year
- +119.0%
- 2 full years
- Best year
- +194.8%
- 2025
- Worst year
- +43.1%
- 2024
- Positive years
- 2/2
- 100% up
Annualized (CAGR)
+3.7%
2024–2026
Average year
+119.0%
2 full years
Best year
+194.8%
2025
Worst year
+43.1%
2024
Positive years
2/2
100% up
Total return by period#
Annual
-100%0%100%
2024+43%'24
2025+195%'25
2026-44%'26
Methodology#
Total returns, dividends reinvested, measured on MLYS. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Mineralys Therapeutics Inc.'s average annual return?
- Since 2024, Mineralys Therapeutics Inc. (MLYS) has returned about 3.7% a year (the compound annual growth rate) and an average calendar-year return of 119.0%.
- What were Mineralys Therapeutics Inc.'s best and worst years?
- Over 2024–2026, the best year was 2025 (+194.8%) and the worst was 2024 (+43.1%).
- How often is Mineralys Therapeutics Inc. up in a year?
- 2 of the 2 full years since 2024 were positive — about 100% of the time.
More on Mineralys Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100